AG
Artal Group Portfolio holdings
AUM
$930M
This Quarter Return
+3.98%
1 Year Return
-3.57%
3 Year Return
+157.23%
5 Year Return
+160.22%
10 Year Return
+1,359.85%
AUM
$2.36B
AUM Growth
–
Cap. Flow
+$2.36B
Cap. Flow
% of AUM
100%
Top 10 Holdings %
Top 10 Hldgs %
89.68%
Holding
72
New
43
Increased
–
Reduced
–
Closed
–
Top Buys
| 1 |
WW
WW International
WW
|
$1.32B |
| 2 |
Lexicon Pharmaceuticals
LXRX
|
$550M |
| 3 |
ACOR
Acorda Therapeutics, Inc.
ACOR
|
$49.5M |
| 4 |
AUXL
AUXILIUM PHARAMCEUTICALS INC
AUXL
|
$43.9M |
| 5 |
FURX
FURIEX PHARMACEUTICALS INC COM STK (DE)
FURX
|
$31.2M |
Top Sells
No sells this quarter
Sector Composition
| 1 | Consumer Discretionary | 56.82% |
| 2 | Healthcare | 31.59% |
| 3 | Financials | 2.41% |
| 4 | Technology | 1.03% |
| 5 | Consumer Staples | 0.67% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
WW
1
DELISTED
WW International
WW
| $1.32B | 41.61% | +28,749,089 | New | +$1.32B |
|
|
2
Lexicon Pharmaceuticals
LXRX
$400M
| $550M | 17.3% | +253,372,135 | New | +$550M |
|
|
ACOR
3
DELISTED
Acorda Therapeutics, Inc.
ACOR
| $49.5M | 1.56% | +1,500,000 | New | +$49.5M |
|
|
AUXL
4
DELISTED
AUXILIUM PHARAMCEUTICALS INC
AUXL
| $43.9M | 1.38% | +2,637,200 | New | +$43.9M |
|
|
FURX
5
DELISTED
FURIEX PHARMACEUTICALS INC COM STK (DE)
FURX
| $31.2M | 0.98% | +914,442 | New | +$31.2M |
|
6
Nektar Therapeutics
NKTR
$568M
| $28.9M | 0.91% | +2,500,000 | New | +$28.9M |
|
|
IMGN
7
DELISTED
Immunogen Inc
IMGN
| $28.2M | 0.89% | +1,700,000 | New | +$28.2M |
|
|
ONXX
8
DELISTED
ONYX PHARMACEUTICALS INC
ONXX
| $26M | 0.82% | +300,000 | New | +$26M |
|
9
Apple
AAPL
$3.45T
| $19.8M | 0.62% | +50,000 | New | +$19.8M |
|
10
BioMarin Pharmaceuticals
BMRN
$11.2B
| $19.5M | 0.61% | +350,000 | New | +$19.5M |
|
11
MetLife
MET
$54.1B
| $18.3M | 0.58% | +400,000 | New | +$18.3M |
|
12
Amgen
AMGN
$155B
| $17.3M | 0.54% | +175,000 | New | +$17.3M |
|
|
ONIT
13
Onity Group Inc.
ONIT
$333M
| $14.4M | 0.45% | +350,000 | New | +$14.4M |
|
|
ARRY
14
DELISTED
Array Biopharma Inc
ARRY
| $13.6M | 0.43% | +3,000,000 | New | +$13.6M |
|
|
CERE
15
DELISTED
CERES, INC. COMMON STOCK NEW
CERE
| $13.1M | 0.41% | +4,192,167 | New | +$13.1M |
|
|
AFFX
16
DELISTED
AFFYMETRIX INC
AFFX
| $12.9M | 0.41% | +2,900,000 | New | +$12.9M |
|
|
AVNR
17
DELISTED
AVANIR PHARMACEUTICALS, INC CL A
AVNR
| $12.7M | 0.4% | +2,750,000 | New | +$12.7M |
|
18
BRF SA
BRFS
$6.12B
| $10.9M | 0.34% | +500,000 | New | +$10.9M |
|
19
Bausch Health
BHC
$2.74B
| $10.8M | 0.34% | +125,000 | New | +$10.8M |
|
20
iShares MSCI Mexico ETF
EWW
$1.78B
| $9.79M | 0.31% | +150,000 | New | +$9.79M |
|
21
IQVIA
IQV
$32.4B
| $9.58M | 0.3% | +225,000 | New | +$9.58M |
|
22
Arcos Dorados Holdings
ARCO
$1.47B
| $9.34M | 0.29% | +800,000 | New | +$9.34M |
|
23
Xoma
XOMA
$392M
| $9.08M | 0.29% | +2,500,000 | New | +$9.08M |
|
24
American International
AIG
$45.1B
| $8.94M | 0.28% | +200,000 | New | +$8.94M |
|
25
Meta Platforms (Facebook)
META
$1.86T
| $6.22M | 0.2% | +250,000 | New | +$6.22M |
|